Pharma Innovator Leverages Digital CPV to Boost Statistical Control and Cut Reporting Time from Two Weeks to Three Days

Laboratório Teuto, a Brazilian pharmaceutical company, faced challenges with manual continued process verification (CPV) activities that were error-prone and inefficient. The company implemented ValGenesis Process Insight to automate data collection and enable real-time monitoring. The results were significant: reporting time was cut from two weeks to three days, and the CPV team was reduced from 16 to 5 members. The digital solution also enhanced data integrity, strengthened audit trails, and improved statistical controls for better decision-making.

ValGenesis is a digital validation-lifecycle platform — one of the two dominant players, alongside Kneat, in producing the validation evidence a GxP system needs before it can go live.

This sits in the Ship stage of the AI use-case lifecycle: Named examples from the vendors pharma teams use to get an AI system live inside a real, regulated production workflow — validation, CRM, safety and clinical systems of record.